Frank Peters

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Breast Cancer Research and Treatment · 2013 · 239 citations

Breast Oncology, Medicine, Pathology +7

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · British Journal of Cancer · 2015 · 233 citations · Full text

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

Astrid E. Slagter, Edwin P. M. Jansen, Hanneke W.M. van Laarhoven et al. · BMC Cancer · 2018 · 147 citations · Full text

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Annals of Oncology · 2015 · 78 citations · Full text

Palliative Care, Nursing, Initial Palliative Therapy +9

Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry

Hans M. Westgeest, Carin A. Uyl‐de Groot, R. Jeroen A. van Moorselaar et al. · European Urology Focus · 2016 · 53 citations · Full text

Urology, Cancer Screening, Medicine +7